• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硬斑病的组织病理学变化及其临床相关性:成人和儿童硬斑病队列V的结果

Histopathological changes in morphea and their clinical correlates: Results from the Morphea in Adults and Children Cohort V.

作者信息

Walker Daniel, Susa Joseph S, Currimbhoy Sharif, Jacobe Heidi

机构信息

Department of Dermatology, University of Arkansas, Fayetteville, Arkansas.

Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas.

出版信息

J Am Acad Dermatol. 2017 Jun;76(6):1124-1130. doi: 10.1016/j.jaad.2016.12.020. Epub 2017 Mar 9.

DOI:10.1016/j.jaad.2016.12.020
PMID:28285783
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5438266/
Abstract

BACKGROUND

Histopathological features in morphea (localized scleroderma) and their clinical correlates are poorly described.

OBJECTIVE

We sought to systematically describe histologic changes of morphea in a large, well-annotated cohort and determine the association between histopathology and clinical features.

METHODS

This was a cross-sectional study of 83 patients enrolled in the Morphea in Adults and Children cohort. The main outcome measure was the association of microanatomical location and degree of sclerosis and inflammation seen on histologic samples with patient-reported symptoms and physician-based measures of severity.

RESULTS

Pattern of sclerosis was associated with morphea subtype, the presence of patient-reported symptoms, and functional limitation. A bottom-heavy pattern of sclerosis was associated with pain and tightness (P = .0039 and .001, respectively). These symptoms were not associated with a top-heavy pattern. Severe inflammation may be associated with pain and functional limitation (P = .073 for both).

LIMITATIONS

Small sample size limits ability to detect associations, particularly in subgroups.

CONCLUSIONS

Histopathological examination of morphea may assist in identifying patients who may require additional monitoring and treatment. Features such as patterns of sclerosis and severity of inflammation should be included in pathology reports to help aid in clinical management.

摘要

背景

硬斑病(局限性硬皮病)的组织病理学特征及其临床相关性描述较少。

目的

我们试图在一个大量且注释完善的队列中系统描述硬斑病的组织学变化,并确定组织病理学与临床特征之间的关联。

方法

这是一项对纳入成人和儿童硬斑病队列的83例患者进行的横断面研究。主要结局指标是组织学样本上观察到的微观解剖位置、硬化程度和炎症程度与患者报告的症状以及医生评估的严重程度之间的关联。

结果

硬化模式与硬斑病亚型、患者报告的症状以及功能受限有关。底部较重的硬化模式与疼痛和紧绷感相关(分别为P = 0.0039和0.001)。这些症状与顶部较重的模式无关。严重炎症可能与疼痛和功能受限有关(两者均为P = 0.073)。

局限性

样本量小限制了检测关联的能力,尤其是在亚组中。

结论

硬斑病的组织病理学检查可能有助于识别可能需要额外监测和治疗的患者。病理报告应包括硬化模式和炎症严重程度等特征,以帮助临床管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/955c/5438266/3a66ba88b91b/nihms838311f2a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/955c/5438266/44ca514e75e7/nihms838311f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/955c/5438266/3a66ba88b91b/nihms838311f2a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/955c/5438266/44ca514e75e7/nihms838311f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/955c/5438266/3a66ba88b91b/nihms838311f2a.jpg

相似文献

1
Histopathological changes in morphea and their clinical correlates: Results from the Morphea in Adults and Children Cohort V.硬斑病的组织病理学变化及其临床相关性:成人和儿童硬斑病队列V的结果
J Am Acad Dermatol. 2017 Jun;76(6):1124-1130. doi: 10.1016/j.jaad.2016.12.020. Epub 2017 Mar 9.
2
Correlates of self-reported quality of life in adults and children with morphea.硬斑病患者成人和儿童自我报告生活质量的相关因素。
J Am Acad Dermatol. 2014 May;70(5):904-10. doi: 10.1016/j.jaad.2013.11.037. Epub 2014 Feb 16.
3
Clinical characteristics and histopathologic changes of morphea: A single-center, retrospective study of 137 patients.硬斑病的临床特征和组织病理学变化:单中心回顾性研究 137 例。
J Am Acad Dermatol. 2021 Jul;85(1):105-113. doi: 10.1016/j.jaad.2020.11.006. Epub 2020 Nov 12.
4
Skin mapping for the classification of generalized morphea.皮肤图谱分类用于广义硬斑病。
J Am Acad Dermatol. 2018 Feb;78(2):351-357. doi: 10.1016/j.jaad.2016.08.052.
5
Morphea patients with mucocutaneous involvement: A cross-sectional study from the Morphea in Adults and Children (MAC) cohort.黏膜皮肤受累硬斑病患者:成人和儿童硬斑病(MAC)队列的横断面研究。
J Am Acad Dermatol. 2021 Jul;85(1):114-120. doi: 10.1016/j.jaad.2020.10.093. Epub 2020 Nov 27.
6
Perineural inflammation in morphea (localized scleroderma): systematic characterization of a poorly recognized but potentially useful histopathological feature.硬斑病(局限性硬皮病)中的神经周围炎症:一种认识不足但可能有用的组织病理学特征的系统表征
J Cutan Pathol. 2014 Jan;41(1):28-35. doi: 10.1111/cup.12242. Epub 2013 Oct 24.
7
Clinical features of patients with morphea and the pansclerotic subtype: a cross-sectional study from the morphea in adults and children cohort.硬斑病和泛发性硬斑病亚型患者的临床特征:一项来自成人和儿童硬斑病队列的横断面研究。
J Rheumatol. 2014 Jan;41(1):106-12. doi: 10.3899/jrheum.130029. Epub 2013 Dec 1.
8
Changes in Disease Activity and Damage Over Time in Patients With Morphea.时间推移中硬斑病患者的疾病活动度和损伤变化。
JAMA Dermatol. 2020 May 1;156(5):513-520. doi: 10.1001/jamadermatol.2020.0034.
9
An Evaluation of the Performance of Current Morphea Subtype Classifications.现行硬斑病亚型分类法性能评估。
JAMA Dermatol. 2021 Apr 1;157(4):1-8. doi: 10.1001/jamadermatol.2020.5809.
10
Linear morphea: Clinical characteristics, disease course, and treatment of the Morphea in Adults and Children cohort.线性硬斑病:成人和儿童硬斑病队列的临床特征、疾病进程和治疗。
J Am Acad Dermatol. 2019 Jun;80(6):1664-1670.e1. doi: 10.1016/j.jaad.2019.01.050. Epub 2019 Apr 17.

引用本文的文献

1
Unique and shared transcriptomic signatures underlying localized scleroderma pathogenesis identified using interpretable machine learning.利用可解释机器学习识别局限性硬皮病发病机制背后独特且共享的转录组特征。
JCI Insight. 2025 Apr 8;10(7):e185758. doi: 10.1172/jci.insight.185758.
2
Characterization of Endothelial Cell Subclusters in Localized Scleroderma Skin with Single-Cell RNA Sequencing Identifies NOTCH Signaling Pathway.单细胞 RNA 测序对局限性硬皮病皮肤中内皮细胞亚群的特征分析显示 NOTCH 信号通路。
Int J Mol Sci. 2024 Sep 28;25(19):10473. doi: 10.3390/ijms251910473.
3
Interferon-Gamma-Inducible Protein-10 (IP-10) and Tumor Necrosis Factor-α (TNF-α) as Serological Predictors of Active Disease Status in Localized Scleroderma.干扰素-γ诱导蛋白-10(IP-10)和肿瘤坏死因子-α(TNF-α)作为局限性硬皮病活动疾病状态的血清学预测指标。
Int J Mol Sci. 2024 Sep 21;25(18):10134. doi: 10.3390/ijms251810134.
4
Histopathologic spectrum of morphea: a single-center retrospective study.硬斑病的组织病理学谱:一项单中心回顾性研究。
Dermatol Reports. 2024 Feb 6;16(3):9915. doi: 10.4081/dr.2024.9915. eCollection 2024 Sep 2.
5
Spatial Transcriptomics Identifies Cellular and Molecular Characteristics of Scleroderma Skin Lesions: Pilot Study in Juvenile Scleroderma.空间转录组学鉴定硬皮病皮肤损伤的细胞和分子特征:青少年硬皮病的初步研究。
Int J Mol Sci. 2024 Aug 23;25(17):9182. doi: 10.3390/ijms25179182.
6
Clinical and ultrasonographic evaluation of efficacy and safety of intralesional injection of autologous platelet-rich plasma in morphea: A comparative case series.局部注射自体富血小板血浆治疗硬斑病的疗效及安全性的临床和超声评估:一项对比病例系列研究
J Scleroderma Relat Disord. 2024 Jun;9(2):162-168. doi: 10.1177/23971983231222664. Epub 2024 Jan 23.
7
Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?与1型相关皮肤炎症性疾病相关的2型免疫:是友还是敌?
Front Immunol. 2024 May 29;15:1405215. doi: 10.3389/fimmu.2024.1405215. eCollection 2024.
8
Clinical and Histological Characteristics of Localized Morphea, Generalized Morphea and Systemic Sclerosis: A Comparative Study Aided by Machine Learning.局限性硬斑病、泛发性硬斑病和系统性硬化症的临床及组织学特征:一项机器学习辅助的对比研究
Acta Derm Venereol. 2023 Sep 20;103:adv11953. doi: 10.2340/actadv.v103.11953.
9
Single-Cell Transcriptome Analysis Identifies Subclusters with Inflammatory Fibroblast Responses in Localized Scleroderma.单细胞转录组分析鉴定局限性硬皮病中具有炎症性成纤维细胞反应的亚群。
Int J Mol Sci. 2023 Jun 6;24(12):9796. doi: 10.3390/ijms24129796.
10
Successful Treatment of Paediatric Morphea with Tofacitinib.托法替布成功治疗儿童硬斑病
Acta Derm Venereol. 2023 Apr 21;103:adv4805. doi: 10.2340/actadv.v103.4805.

本文引用的文献

1
The role of skin trauma in the distribution of morphea lesions: a cross-sectional survey of the Morphea in Adults and Children cohort IV.皮肤创伤在硬斑病皮损分布中的作用:成人及儿童硬斑病队列IV的横断面调查
J Am Acad Dermatol. 2014 Sep;71(3):493-8. doi: 10.1016/j.jaad.2014.04.009. Epub 2014 May 28.
2
Mechanisms of fibrosis: therapeutic translation for fibrotic disease.纤维化机制:纤维化疾病的治疗转化。
Nat Med. 2012 Jul 6;18(7):1028-40. doi: 10.1038/nm.2807.
3
Morphea in adults and children cohort II: patients with morphea experience delay in diagnosis and large variation in treatment.成人和儿童硬斑病队列研究 II:硬斑病患者的诊断存在延迟,治疗存在较大差异。
J Am Acad Dermatol. 2012 Nov;67(5):881-9. doi: 10.1016/j.jaad.2012.01.011. Epub 2012 Feb 29.
4
14-MHz ultrasonography as an outcome measure in morphea (localized scleroderma).14兆赫超声检查作为硬斑病(局限性硬皮病)的一项疗效指标
Arch Dermatol. 2011 Sep;147(9):1112-5. doi: 10.1001/archdermatol.2011.243.
5
Initial evaluation of an ultrasound measure for assessing the activity of skin lesions in juvenile localized scleroderma.评估超声在评估青少年局限性硬皮病皮肤病变活动性中的应用。
Arthritis Care Res (Hoboken). 2011 May;63(5):735-42. doi: 10.1002/acr.20407.
6
Cytokine profiles in localized scleroderma and relationship to clinical features.局限性硬皮病的细胞因子谱及其与临床特征的关系。
Cytokine. 2011 Aug;55(2):157-64. doi: 10.1016/j.cyto.2011.04.001. Epub 2011 May 4.
7
Update on morphea: part II. Outcome measures and treatment.硬斑病的最新进展:第二部分。结局评估与治疗。
J Am Acad Dermatol. 2011 Feb;64(2):231-42; quiz 243-4. doi: 10.1016/j.jaad.2010.05.046.
8
An evaluation of long-term outcomes in adults with pediatric-onset morphea.儿童期发病的硬斑病成人患者的长期预后评估。
Arch Dermatol. 2010 Sep;146(9):1044-5. doi: 10.1001/archdermatol.2010.239.
9
Development and initial validation of the localized scleroderma skin damage index and physician global assessment of disease damage: a proof-of-concept study.局限性硬皮病皮肤损伤指数和医生对疾病损伤的整体评估的本地化开发和初步验证:概念验证研究。
Rheumatology (Oxford). 2010 Feb;49(2):373-81. doi: 10.1093/rheumatology/kep361. Epub 2009 Dec 14.
10
MRI findings in deep and generalized morphea (localized scleroderma).深部和泛发性硬斑病(局限性硬皮病)的磁共振成像表现
AJR Am J Roentgenol. 2008 Jan;190(1):32-9. doi: 10.2214/AJR.07.2163.